Canary Speech

United States
Provo, Utah, United States, 84604

Company profile

Canary Speech company profile

Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring. The company's vocal biomarker technology enables voice to be used as a vital sign, ushering in a new era of machine learning in healthcare. Using only 20 seconds of conversational speech, its patented vocal biomarker technology models acoustic and linguistic features and returns analysis. Canary detects stress, mood, and energy levels before traditional clinical screening and visible symptoms, allowing clinicians, payers, and patients to address conditions more proactively. Canary's technology reduces readmissions, prevents hospitalizations, and provides a head start on wellness for patients and providers. Its current research simulates respiratory conditions, dementia and Alzheimer's disease, and clinical deterioration, with broad practical implications for simulating other disease states.

Business identity

Contact email
[email protected]
Phone number
801-376-2221
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2016-01-01, Year

Headquarters

Postal code
84604
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$22.3M
Last funding
Series Unknown / $4.1M / 2025-01-06
Last equity funding
Series Unknown / $4.1M
Investors
4
Lead investors
1
Founders
2
Articles
53

Founders and investors

Founders

Henry O'ConnellJeff Adams

Lead investors

Cortes capital

Investors

Cortes capitalHackensack Meridian HealthSMK CorporationSorenson Communications